Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma

被引：0
|
作者：
Emilia Hugdahl
May Britt Kalvenes
Monica Mannelqvist
Rita G Ladstein
Lars A Akslen
机构：
[1] Centre for Cancer Biomarkers CCBIO,Department of Clinical Medicine
[2] University of Bergen,Department of Dermatology
[3] Haukeland University Hospital,Department of Pathology
[4] Haukeland University Hospital,undefined
来源：
British Journal of Cancer | 2018年 / 118卷
关键词：
nodular melanoma; metastases; promoter mutation; TERT protein expression; prognosis; inter-tumoural discordance; intra-tumoural discordance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：98 / 105
页数：7
相关论文
共 50 条
  • [31] The impact of metastatic sites on checkpoint inhibitor outcomes in patients with cutaneous and unknown primary melanoma
    Krieger, Penina
    Sanchez-Vega, Francisco
    Schultz, Nikolaus
    Shoushtari, Alexander
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [32] PRL-3 expression - Possible prognostic and predictive marker in primary cutaneous melanoma
    Lim, M. G.
    Lawson, D.
    Coisonis, G.
    Chang, X. J.
    Shou, C.
    Stein, I. M.
    Cohen, C.
    MODERN PATHOLOGY, 2008, 21 : 97A - 97A
  • [33] PRL-3 expression - Possible prognostic and predictive marker in primary cutaneous melanoma
    Lim, M. G.
    Lawson, D.
    Cotsonis, G.
    Chang, X. J.
    Shou, C.
    Stein, I. M.
    Cohen, C.
    LABORATORY INVESTIGATION, 2008, 88 : 97A - 97A
  • [34] Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness
    Ribero, Simone
    Galli, Francesca
    Osella-Abate, Simona
    Bertero, Luca
    Cattaneo, Laura
    Merelli, Barbara
    Tondini, Carlo
    Ghilardi, Laura
    De Giorgi, Vincenzo
    Occelli, Marcella
    Quaglino, Pietro
    Cassoni, Paola
    Palmieri, Giuseppe
    Massi, Daniela
    Mandala, Mario
    Queirolo, Paola
    Stanganelli, Ignazio
    Botti, Gerardo
    Caraco, Corrado
    Sileni, Vanna Chiarion
    Di Giacomo, Anna Maria
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) : 99 - +
  • [35] SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma
    Populo, Helena
    Batista, Rui
    Sampaio, Cristina
    Pardal, Joana
    Lopes, Jose Manuel
    Soares, Paula
    PLOS ONE, 2017, 12 (06):
  • [36] Expression of cancer-testis antigens is a poor prognostic factor in primary but not metastatic melanoma
    Azad, A.
    Svobodova, S.
    Browning, J.
    MacGregor, D.
    Deb, S.
    Davis, I.
    Cebon, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 584 - 584
  • [37] Next-Generation Sequencing of Matched Primary and Metastatic Rectal Adenocarcinomas Demonstrates Minimal Mutation Gain and Concordance to Colonic Adenocarcinomas
    Crumley, Suzanne M.
    Pepper, Kristi L.
    Phan, Alexandria T.
    Olsen, Randall J.
    Schwartz, Mary R.
    Portier, Bryce P.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (06) : 529 - 535
  • [38] The Clinicopathological and Prognostic Features of Promoter Mutation, Rs2853669 Polymorphism and Methylation within the TERT Gene in Chinese Melanoma Patients
    Hu, Jue
    Cai, Xu
    Kong, Yunyi
    LABORATORY INVESTIGATION, 2024, 104 (03) : S529 - S530
  • [39] The impact of multiple primary cutaneous melanomas on survival of 2,942 patients with metastatic melanoma
    Murali, R.
    Brown, P. T.
    Kefford, R.
    Thompson, J. F.
    Atkins, M. B.
    Long, G. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] S-100 PROTEIN, A USEFUL MARKER IN PATIENTS WITH PRIMARY OR METASTATIC CUTANEOUS AND OCULAR MELANOMA
    COCHRAN, AJ
    WEN, DR
    HOLLAND, GN
    HERSCHMAN, HR
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 1984, 57 (03): : 348 - 349
12345